Ovidrel

Drug

Drug Profile

Ovidrel is a recombinant human chorionic gonadotropin alfa injection used in infertility treatment. It is used to trigger final follicular maturation/ovulation in assisted reproductive technology and ovulation induction settings. Ovidrel is a prescription gonadotropin product in clinical use in the United States.

Drug Class
Gonadotropin fertility hormone
Approval Status
Prescription gonadotropin product with U.S. package insert and FDA drug history listing.
Mechanism of Action
LH analog that binds ovarian LH/hCG receptors to stimulate late follicular maturation, oocyte meiosis resumption, and ovulatory follicle rupture.
Brand Names
  • Ovidrel
Indications
  • \Induction of final follicular maturation and early luteinization in infertile women in ART programs\
  • \Induction of ovulation and pregnancy in anovulatory infertile patients with functional infertility\

Related News

TrumpRx Platform Launches With Mixed Savings on Prescription Drugs

The Trump administration launched TrumpRx.gov in February 2026, offering discounted prices on dozens of brand-name prescription drugs through negotiated deals with pharmaceutical companies, though critics warn many listed drugs have cheaper generic alternatives.

Related Clinical Trials

NCT ID Title Status Phase
NCT07557615

hCG Treatment for Rehabilitation From a TBI

NOT_YET_RECRUITING EARLY_PHASE1
NCT04717752

A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

UNKNOWN NA
NCT03540979

Endometrial Preparation in Frozen Embryo Transfer Cycles

UNKNOWN NA